References
- Sortino M, Delgado P, Juárez S, et al. Synthesis and antifungal activity of (Z)-5-arylidenerhodanines. Bioorg Med Chem 2007;15:484–94
- Grant EB, Guiadeen D, Baum EZ, et al. The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors. Bioorg Med Chem Lett 2000;10:2179–82
- Sing WT, Lee CL, Yeo SL, et al. Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor. Bioorg Med Chem Lett 2001;11:91–4
- Fujishima H, Tsubota K. Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235. Br J Ophthalmol 2002;86:860–3
- Sim MM, Ng SB, Buss AD, et al. Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/l-alanine ligase. Bioorg Med Chem Lett 2002;12:697–9
- Irvine MW, Patrick GL, Kewney J, et al. Rhodanine derivatives as novel inhibitors of PDE4. Bioorg Med Chem Lett 2008;18:2032–7
- Liu J, Wu F, Chen L, et al. Evaluation of dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase inhibitors. Bioorg Med Chem Lett 2011;21:2376–9
- Terashima H, Hama K, Yamamoto R, et al. Effects of a new aldose reductase inhibitor on various tissues in vitro. J Pharmacol Exp Ther 1984;229:226–30
- Murata M, Fujitani B, Mizuta H. Synthesis and aldose reductase inhibitory activity of a new series of 5-[[2-(ω-carboxyalkoxy)aryl]methylene]-4-oxo-2-thioxothiazolidine derivatives. Eur J Med Chem 1999;34:1061–70
- Bulic B, Pickhardt M, Schmidt B, et al. Development of tau aggregation inhibitors for Alzheimer's disease. Angew Chem Int Ed 2009;48:1740–52
- Hotta N, Akanuma Y, Kawamori R, et al. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care 2006;29:1538–44
- Bulic B, Pickhardt M, Khlistunova I, et al. Rhodanine-based tau aggregation inhibitors in cell models of tauopathy. Angew Chem Int Ed 2007;46:9215–19
- Roman OM, Nektegayev IO, Lesyk RB. Bioactive compounds among 5-arylidenerhodanine 3-carboxylic acids. Pharm J 2002;5:47–51 (in Ukrainian)
- Roman OM, Nektegayev IO, Mountains VJ, et al. Synthesis and anti-inflammatory activity of 3-aryl-5-arylidene-2-thioxothiazolidin-4-ones. Pharm J 2002;3:56--9 (in Ukrainian)
- Alipour M, Khoobi M, Nadri H, et al. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase. Arch Pharm 2013;346:577–87
- Khoobi M, Alipour M, Sakhteman A, et al. Design, synthesis, biological evaluation and docking study of 5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors. Eur J Med Chem 2013;68:260–9
- Razavi SF, Khoobi M, Nadri H, et al. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors. Eur J Med Chem 2013;64:252–9
- Nadri H, Pirali-Hamedani M, Moradi A, et al. 5,6-Dimethoxybenzofuran-3-one derivatives: a novel series of dual acetylcholinesterase/butyrylcholinesterase inhibitors bearing benzyl pyridinium moiety. Daru 2013;21:15. doi: 10.1186/2008-2231-21-15
- Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455–61
- Sanner MF. Python: a programming language for software integration and development. J Mol Graph Model 1999;17:57–61
- O'Boyle NM, Banck M, James CA, et al. Open babel: an open chemical toolbox. J Cheminform 2011;3:33. doi: 10.1186/1758-2946-3-33
- Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera – a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–12
- Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95
- Malterud KE, Rydland KM. Inhibitors of 15-lipoxygenase from orange peel. J Agric Food Chem 2000;48:5576–80
- Hardej D, Ashby Jr CR, Khadtare NS, et al. The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains. Eur J Med Chem 2010;45:5827–32
- Dolezel J, Hirsova P, Opletalova V, et al. Rhodanineacetic acid derivatives as potential drugs: preparation, hydrophobic properties and antifungal activity of (5-arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)acetic acids. Molecules 2009;14:4197–212